GlaxoSmithKline

GSK: 1,557.60 +47.00 (+3.11%) delayed: 19 Oct 2018, 18:28

Trade now
Bid Price 1,557.20 High Price 1,558.40
Ask Price 1,557.60 Low Price 1,516.00
Open Price 1,523.20 Spread 0.03%
Prev Close 1,557.60 Volume 13,434,174

GlaxoSmithKline Share Price

Intraday
Historic - 6 months
>> Advanced GlaxoSmithKline Charts >>

GlaxoSmithKline Share Price Information

Name GlaxoSmithKline
Epic GSK
Sector Pharmaceuticals & Biotechnology
ISIN GB0009252882
Activites GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders. GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Around 35,000 employees work at 82 manufacturing sites in 37 countries and over 15,000 are in R&D. GSK R&D is based at 24 sites in 11 countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.8bn/$5bn.
Index n/a
Latest Share Price (p) 1,557.60 Net Gearing (%) 87.01
Market Capitalisation (£m) 74,129.41 Gross Gearing (%) 93.81
Shares in issue (m) 4,960.48 Debt Ratio 88.30
P/E Ratio 47.59 Debt-to-Equity Ratio 0.50
Total dividends per share (p) 80.00 Assets / Equity Ratio 16.16
Dividend Yield (%) 5.35 Price to book value 21.25
Dividend Cover 0.39 ROCE (%) 11.82
Earning per share (p) 31.40 EPS Growth (%) 67.02
52-week high / low (p) 1,625.00 / 1,236.40 DPS Growth (%) 0.00

GlaxoSmithKline Broker Views

Date Broker Recommendation Price Old Target Price New Target Price Notes
19 Oct Barclays Capital Overweight 1,557.60 1,750.00 - Reiterates
15 Oct Barclays Capital Overweight 1,557.60 1,750.00 - Reiterates
09 Oct Barclays Capital Overweight 1,557.60 1,750.00 - Reiterates
08 Oct Deutsche Bank Hold 1,557.60 1,525.00 - Reiterates
27 Sep UBS Buy 1,557.60 1,700.00 - Unchanged
>> More GlaxoSmithKline Broker Views >>

GlaxoSmithKline Director Deals

Date Director Type Volume / Price Trade Value
18 Oct 2018 Simon Dingemans Dividend Reinvestment 2,083 @ 1,451.60p £30,236.83
17 Oct 2018 Simon Dingemans Dividend Reinvestment 1,518 @ 1,451.60p £22,035.29
17 Oct 2018 Emma Walmsley Dividend Reinvestment 1,659 @ 1,451.60p £24,082.04
16 Oct 2018 Simon Dingemans Dividend Reinvestment 1,086 @ 1,458.79p £15,842.46
16 Oct 2018 Emma Walmsley Buy 1,588 @ 1,458.79p £23,165.59
>> More GlaxoSmithKline Director Deals >>

GlaxoSmithKline News

>> More GlaxoSmithKline News >>